Janus Henderson Investors US’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Janus Henderson Investors US's CELG Position: Q1 2017 in Review
Janus Henderson Investors US reduced its Celgene Corp (CELG) stake by 7.1% in Q1 2017, selling an estimated $73M and leaving 7,923,248 shares worth $986M. The position accounts for 0.81% of the portfolio, ranked #14.
Janus Henderson Investors US first reported a position in CELG in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.62B in Q3 2013. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.
- Janus Henderson Investors US held 7,923,248 shares of Celgene Corp worth $986M as of Q1 2017.
- Janus Henderson Investors US sold 609,724 Celgene Corp shares in Q1 2017, an estimated $73M.
- Celgene Corp made up 0.81% of Janus Henderson Investors US's portfolio in Q1 2017, its #14 holding.
- Janus Henderson Investors US first reported a position in Celgene Corp in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's Celgene Corp position peaked at $1.62B in Q3 2013.
- 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.